Abstract:BACKGROUND:Alzheimer's disease (AD) is the most common form of dementia, characterized by progressive cognitive impairment and neurodegeneration. However, despite extensive clinical and genomic studies, the molecular basis of AD development and progression remains elusive.METHODS:To elucidate molecular systems associated with AD, we developed a large scale gene expression dataset from 1053 postmortem brain samples across 19 cortical regions of 125 individuals with a severity spectrum of dementia and neuropathology of AD. We excluded brain specimens that evidenced neuropathology other than that characteristic of AD. For the first time, we performed a pan-cortical brain region genomic analysis, characterizing the gene expression changes associated with a measure of dementia severity and multiple measures of the severity of neuropathological lesions associated with AD (neuritic plaques and neurofibrillary tangles) and constructing region-specific co-expression networks. We rank-ordered 44,692 gene probesets, 1558 co-expressed gene modules and 19 brain regions based upon their association with the disease traits.RESULTS:The neurobiological pathways identified through these analyses included actin cytoskeleton, axon guidance, and nervous system development. Using public human brain single-cell RNA-sequencing data, we computed brain cell type-specific marker genes for human and determined that many of the abnormally expressed gene signatures and network modules were specific to oligodendrocytes, astrocytes, and neurons. Analysis based on disease severity suggested that: many of the gene expression changes, including those of oligodendrocytes, occurred early in the progression of disease, making them potential translational/treatment development targets and unlikely to be mere bystander result of degeneration; several modules were closely linked to cognitive compromise with lesser association with traditional measures of neuropathology. The brain regional analyses identified temporal lobe gyri as sites associated with the greatest and earliest gene expression abnormalities.CONCLUSIONS:This transcriptomic network analysis of 19 brain regions provides a comprehensive assessment of the critical molecular pathways associated with AD pathology and offers new insights into molecular mechanisms underlying selective regional vulnerability to AD at different stages of the progression of cognitive compromise and development of the canonical neuropathological lesions of AD.

Functional molecular network models for the genetic risk factors of Alzheimer’s disease: Genetics/omics and systems biology

Identifying Shared Diagnostic Genes and Mechanisms in Vascular Dementia and Alzheimer's Disease Via Bioinformatics and Machine Learning

An Integrated Brain-Specific Network Identifies Genes Associated with Neuropathologic and Clinical Traits of Alzheimer's Disease.

An integrated brain-specific network identifies genes associated with neuropathologic and clinical traits of Alzheimer’s disease

Systems genetic dissection of Alzheimer's disease brain gene expression networks

Genomics and Functional Genomics of Alzheimer’s Disease

Integrative-omics for discovery of network-level disease biomarkers: a case study in Alzheimer's disease

Multivariate genome wide association and network analysis of subcortical imaging phenotypes in Alzheimer's disease

Systems biology and gene networks in Alzheimer’s disease

Gene networks and systems biology in Alzheimer's disease: Insights from multi‐omics approaches

Revealing the Molecular Mechanisms of Alzheimer’s Disease Based on Network Analysis

Functional characterization of Alzheimer's disease genetic variants in microglia

Decoding the genetic comorbidity network of Alzheimer's disease

Deep Post-Gwas Analysis Identifies Potential Risk Genes and Risk Variants for Alzheimer’s Disease, Providing New Insights into Its Disease Mechanisms

ACCELERATING MEDICINES PARTNERSHIP: CO-EXPRESSION NETWORKS

Genome-wide prediction and integrative functional characterization of Alzheimer’s disease-associated genes

Deep Trans-Omic Network Fusion for Molecular Mechanism of Alzheimer's Disease

Beyond association: successes and challenges in linking non-coding genetic variation to functional consequences that modulate Alzheimer's disease risk

Genetic and multi-omic risk assessment of Alzheimer's disease implicates core associated biological domains

Integrative Network Analysis of Nineteen Brain Regions Identifies Molecular Signatures and Networks Underlying Selective Regional Vulnerability to Alzheimer’s Disease

Network Medicine Approach for Analysis of Alzheimer's Disease Gene Expression Data.